Alagille Syndrome (ALGS ... outcomes in children with ALGS are comparable to those in children with biliary atresia, a common liver disease in infants. A study utilizing linked databases found ...

In unusual circumstances, Ipsen has been given the green light for its odevixibat drug for severe itching (pruritus) in patients with rare liver disease Alagille syndrome (ALGS) in the EU – for ...

After various twists and turns in the regulator path, Ipsen has secured EU approval for Kayfanda, its treatment for severe itching (pruritus) in patients with the rare liver disease Alagille ...